As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there
have been increasing reports from Europe, North America, Asia, and Latin America …

Abstract Multisystem Inflammatory Syndrome in Children (MIS-C) is a new phenomenon
reported worldwide with temporal association with Covid-19. The objective of this paper is to …

An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2
was recently published and termed pediatric inflammatory multisystem syndrome, temporally …

Initial reports on COVID-19 described children as largely spared from severe manifestations,
with only 2–6% of children requiring intensive care treatment. However, since mid-April …

End of April 2020, French clinicians observed an increase in cases presenting with
paediatric inflammatory multisystem syndrome (PIMS). Nationwide surveillance was set up …

Background: Recently, severe manifestations associated with coronavirus disease 2019
(COVID-19) called multisystem inflammatory syndrome in children (MIS-C) have been …

Early reports of COVID-19 in pediatric populations emphasized a mild course of disease
with severe cases disproportionately affecting infant and comorbid pediatric patients. After …

Objectives We describe the presentation, treatment and outcome of children with
multisystem inflammatory syndrome with COVID-19 (MIS-C) in Mumbai metropolitan area in …

The diverse clinical manifestations of COVID-19 is emerging as a hallmark of the Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. While the initial target …

Background We describe the demographic, clinical and laboratory findings along with the
treatment and outcomes among children meeting the case definition of Pediatric …